- Category
- Micro (2021-22)
- Udyam number
- UDYAM-GJ-22-0155513

Raxia Pharmaceutical Private Limited
About Raxia Pharmaceutical Private Limited
Data last updated:
Raxia Pharmaceutical Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 February 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2022PTC129496.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Mayur Parshottambhai Khadsaliya and Rita Piyushbhai Khadsaliya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. F – 19 Sunrise Residency Utaran Main Road, Surat, Gujarat, India – 394105.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.23 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3,380 (net margin 0.2%) and EBITDA of ₹4,010 (EBITDA margin 0.3%).
Raxia Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0155513).
Company details
Recognitions & Rankings of Raxia Pharmaceutical
Contact details
Raxia Pharmaceutical Private Limited's registered office is in Surat, Gujarat.
- Registered AddressShop No. F – 19 Sunrise Residency Utaran Main Road, Surat, Gujarat, India – 394105
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raxia Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Raxia Pharmaceutical Private Limited, buy the company report.
Financials of Raxia Pharmaceutical Private Limited
FY 2025 filings availableRaxia Pharmaceutical Private Limited reported revenue of ₹15.23 Lakh (up 228% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 228% in the latest year. EBITDA rose 40% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹4,010 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹3,380 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.3% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Raxia Pharmaceutical Private Limited, buy the company report.
Board of directors of Raxia Pharmaceutical Private Limited
Raxia Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayur Parshottambhai Khadsaliya | Director | 18 Feb 2022 | 4 Years 8 Months | Current |
| Rita Piyushbhai Khadsaliya | Director | 18 Feb 2022 | 4 Years 8 Months | Current |
| Piyushkumar Parsottambhai Khadsaliya | Director | 18 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Raxia Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Noble Translink Private Limited | ₹15.25 Lakh (FY 2021) | -84.0% | Amritsar, Punjab, India | |||
| KRR Industries Private Limited | ₹15.25 Lakh (FY 2023) | 128.0% | New Delhi, Delhi, India | |||
| Debaudyan Herbal Private Limited | ₹15.24 Lakh (FY 2020) | 1496.0% | Odisha, India | |||
| Global Nanotech Private Limited | ₹15.24 Lakh (FY 2024) | -66.0% | Ahmedabad, Gujarat, India | |||
| Adrena Life Sciences Private Limited | ₹15.24 Lakh (FY 2023) | Bangalore, Karnataka, India | ||||
| Raxia Pharmaceutical Private Limitedthis company | ₹15.23 Lakh (FY 2024) | ₹3,380 | 0.2% | 228.0% | Surat, Gujarat, India | |
| Lars Lifecare Private Limited | ₹15.23 Lakh (FY 2022) | Thrissur, Kerala, India | ||||
| Kanj Care Private Limited | ₹15.23 Lakh (FY 2024) | -70.0% | Haridwar, Uttarakhand, India | |||
| Twak Health Care Private Limited | ₹15.22 Lakh (FY 2025) | 577.0% | Ahmedabad, Gujarat, India | |||
| Ummees Naturals Private Limited | ₹15.21 Lakh (FY 2023) | Palakkad, Kerala, India | ||||
| Eurosun Biopharma Private Limited | ₹15.21 Lakh (FY 2019) | 127.0% | Pune, Maharashtra, India |
To see the full peer comparison of Raxia Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Raxia Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raxia Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Raxia Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Raxia Pharmaceutical Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Mayur Parshottambhai Khadsaliya was appointed as Director on 18 Feb 2022.
Frequently asked questions
Raxia Pharmaceutical is an active private limited company based in Surat, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 February 2022 (4+ years old) and is registered under CIN U24230GJ2022PTC129496.
Raxia Pharmaceutical has 3 current directors:
- Mayur Parshottambhai Khadsaliya - Director
- Rita Piyushbhai Khadsaliya - Director
- Piyushkumar Parsottambhai Khadsaliya - Director
The latest financial statements of Raxia Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Raxia Pharmaceutical is U24230GJ2022PTC129496. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raxia Pharmaceutical was incorporated on 18 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Raxia Pharmaceutical by revenue are Noble Translink Private Limited, KRR Industries Private Limited, Debaudyan Herbal Private Limited, Global Nanotech Private Limited, Adrena Life Sciences Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mayur Parshottambhai Khadsaliya was appointed as Director on 18 Feb 2022. Piyushkumar Parsottambhai Khadsaliya was appointed as Director on 18 Feb 2022. Rita Piyushbhai Khadsaliya was appointed as Director on 18 Feb 2022.
Yes, Raxia Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-22-0155513).
The registered office of Raxia Pharmaceutical is at Shop No. F – 19 Sunrise Residency Utaran Main Road, Surat, Gujarat, India – 394105.
Raxia Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Raxia Pharmaceutical can be reached at its registered office: Shop No. F – 19 Sunrise Residency Utaran Main Road, Surat, Gujarat, India – 394105.

